CHIARUGI, VINCENZO
CHIARUGI, VINCENZO
Acetylation and phosphorylation of the carboxy-terminal domain of p53: regulative significance
1998 V.CHIARUGI; M.CINELLI; L.MAGNELLI
Altered platelet function in cirrhosis of the liver: impairment of inositol lipid and arachidonic acid metabolism in response to agonists
1988 G. LAFFI; F. COMINELLI; M. RUGGIERO; S. FEDI; V. CHIARUGI; G. LA VILLA; M. PINZANI; P. GENTILINI
Angiogenesis and the unique nature of tumor matrix
2002 V. CHIARUGI; M. RUGGIERO; L. MAGNELLI
APOPTOSIS - MOLECULAR REGULATION OF CELL DEATH AND HEMATOLOGIC MALIGNANCIES
2001 V. CHIARUGI; P. DELLO SBARBA; L. MAGNELLI; M. CINELLI
Apoptosis induction in 32D cells by IL-3 withdrawal id preceded by a drop in the intracellular calcium level
1993 Magnelli, Lucia; Cinelli, Marina; Turchetti, A.; Chiarugi, Vincenzo
Apoptosis, senescence, immortalization and cancer.
1994 V. CHIARUGI; L. MAGNELLI; M. RUGGIERO
Apoptosis: molecular regulation of cell death and hematologic malignancies.
2002 V.Chiarugi; M.Cinelli; L.Magnelli; P. DELLO SBARBA
Association between vitamin D receptor gene polymorphism and nephrolitiasis
1999 M. RUGGIERO;S. PACINI;M. AMATO;S. ATERINI;V. CHIARUGI
bcl-2 overexpression abolishes early calcium waving preceding apoptosis in NIH-3T3 murine fibroblasts
1994 L.Magnelli; M.Cinelli; A.Turchetti; V.Chiarugi
Binding, internalization and degradation of heparin and heparin fragments by cultured endothelial cells
1988 S.VANNUCCHI; F.PASQUALI; F.PORCIATTI; V.CHIARUGI; L.MAGNELLI; P.BIANCHINI
Brn-3a, a neuronal transcription factor of the POU gene family: indications for its involvement in cancer and angiogenesis.
2002 V. CHIARUGI; M. DEL ROSSO; L. MAGNELLI
CELL SURFACE GLYCOSAMINOGLYCANS IN NORMAL END LEUKEMIC LEUKOCYTES.
1980 R. CAPPELLETTI; V. CHIARUGI; S. VANNUCCHI; M. DEL ROSSO; G. FIBBI; C. CELLAI
Cell survival and death programmes.
1994 V.CHIARUGI; L.MAGNELLI; A.TURCHETTI; M.CINELLI; S.CAVARI; M.RUGGIERO
Cell-type-independent accumulation of phosphatidic acid induced by trifluoperazine in stimulated human platelets, leukocytes and fibroblasts
1984 M. RUGGIERO; G. FIBBI; M. DEL ROSSO; S. VANNUCCHI; F. PASQUALI; V. CHIARUGI
Chronic treatment of human fibroblasts cultures with diacyl-glycerol induces down-regulation of p53 functional activity.
1998 L.MAGNELLI; M.CINELLI; V.CHIARUGI
CITOKINE RECEPTOR SIGNAL TRANSDUCTION MECHANISMS IN IMMUNO-HEMATOPOIETIC CELLS
1993 V. CHIARUGI; P. DELLO SBARBA; M. RUGGIERO; L. MAGNELLI; S. PACINI
Complex interplay among apoptosis factors: RB, p53, E2F, TGF-beta, cell cycle inhibitors and the bcl2 gene family.
1997 V.CHIARUGI; M.CINELLI; L.MAGNELLI
Cox-2, iNOS and p53 as play-makers of tumor angiogenesis (review).
1998 V.CHIARUGI; L.MAGNELLI; O.GALLO
Cyclooxygenase-2 pathway correlates with VEGF expression in head and neck cancer. Implications for tumor angiogenesis and metastasis.
2001 O. GALLO; FRANCHI A.; MAGNELLI L.; SARDI I.; VANNACCI A.; BODDI V.; CHIARUGI V.; MASINI E.
Dominant oncogenes, tumor suppressors and radiosensitivity
1995 V. CHIARUGI; L. MAGNELLI; M. CINELLI; A. TURCHETTI; M. RUGGIERO